SCHEMBL29664488

SCHEMBL29664488

N#Cc1cc2c(nc1I)OCO2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 5/20 0.37
HSD17B10 Q99714 5/20 0.37
ALDH1A1 P00352 5/20 0.37
RXFP1 Q9HBX9 4/20 0.37
GAA P10253 3/20 0.37
HPGD P15428 3/20 0.37
KDM4E B2RXH2 3/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
NPC1 O15118 6/20 0.34
RAB9A P51151 5/20 0.34
MAPT P10636 5/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
PPARG P37231 2/20 0.34
NCOA2 Q15596 2/20 0.34
NCOA1 Q15788 2/20 0.34
NCOA3 Q9Y6Q9 2/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24517531 1.00 NPSR1 (0.37) NPSR1HSD17B10ALDH1A1RXFP1GAA
SCHEMBL29664483 0.79 ALDH1A1 (0.41) NPSR1HSD17B10ALDH1A1RXFP1GAA
SCHEMBL24517477 0.79 ALDH1A1 (0.41) NPSR1HSD17B10ALDH1A1RXFP1GAA
SCHEMBL4145121 0.72 NPC1 (0.40) NPSR1HSD17B10ALDH1A1RXFP1GAA
SCHEMBL26639929 0.69 HPGD (0.39) NPSR1HSD17B10ALDH1A1RXFP1GAA
SCHEMBL26639798 0.67 MAPT (0.37) NPSR1HSD17B10ALDH1A1RXFP1GAA
SCHEMBL24517530 0.65 KDM4E (0.45) NPSR1HSD17B10ALDH1A1RXFP1GAA
SCHEMBL14172609 0.64 CYP3A4 (0.42) NPSR1HSD17B10ALDH1A1RXFP1GAA
SCHEMBL10979117 0.64 MAPT (0.47) NPSR1HSD17B10ALDH1A1RXFP1GAA
SCHEMBL1622661 0.64 MAPT (0.43) NPSR1HSD17B10ALDH1A1RXFP1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022121805-A1 FUSED RING COMPOUND AS NAV1.8 INHIBITOR AND USE THEREOF 成都康弘药业集团股份有限公司 2022-06-16 WO disclosed